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Abstract
The role of p110d PI3K in lymphoid cells has been studied extensively, showing its importance in immune cell
differentiation, activation and development. Altered T cell localization in p110d-deficient mouse spleen suggested a role for
p110d in non-hematopoietic stromal cells, which maintain hematopoietic cell segregation. We tested this hypothesis using
p110dWT/WT mouse bone marrow to reconstitute lethally irradiated p110dWT/WT or p110dD910A/D910A (which express
catalytically inactive p110d) recipients, and studied localization, number and percentage of hematopoietic cell subsets in
spleen and lymph nodes, in homeostatic conditions and after antigen stimulation. These analyses showed diffuse T cell
areas in p110dD910A/D910A and in reconstituted p110dD910A/D910A mice in homeostatic conditions. In these mice, spleen CD4+
and CD8+ T cell numbers did not increase in response to antigen, suggesting that a p110dD910A/D910A stroma defect impedes
correct T cell response. FACS analysis of spleen stromal cell populations showed a decrease in the percentage of
gp382CD31+ cells in p110dD910A/D910A mice. qRT-PCR studies detected p110d mRNA expression in p110dWT/WT spleen
gp382CD31+ and gp38+CD31+ subsets, which was reduced in p110dD910A/D910A spleen. Lack of p110d activity in these cell
populations correlated with lower LTbR, CCL19 and CCL21 mRNA levels; these molecules participate in T cell localization to
specific spleen areas. Our results could explain the lower T cell numbers andmore diffuse T cell areas found in p110dD910A/D910A
mouse spleen, as well as the lower T cell expansion after antigen stimulation in p110dD910A/D910A compared with p110dWT/WT
mice.
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Introduction
Secondary lymphoid organs (SLO) are sites of highly organized
lymphoid cell accumulation, supported by a network of stromal
cells. This network facilitates effective encounter and interaction
between antigen-presenting cells and lymphocytes, maximizing
effectiveness of the immune response to pathogens. Lymph nodes
(LN) and spleen are the best-studied SLO. The spleen has two
well-defined areas. In the red pulp, macrophage-lined venous
sinuses filter damaged erythrocytes from the blood and allow
surveillance of blood-borne pathogens and large antigens. The
white pulp is a compartmentalized lymphoid area that is
specialized in antigen presentation [1]. Within the white pulp, T
and B lymphocytes are segregated into specific areas. Around the
central arteriole, T cells are located in the periarteriolar lymphoid
sheath (PALS or T cell zone), surrounded by the B cell zone (B cell
follicles) [2] . Specific chemokines that attract T and B cells to their
respective areas maintain correct organization of the white pulp
[1]. The marginal zone (MZ) separates the red and white pulp and
contains mainly phagocytic macrophages (marginal metallophilic
macrophages (MMM)), marginal zone macrophages (MZ M),
marginal zone B cells (MZ B) and DC [2]. In LN, naı¨ve
lymphocytes extravasate from the bloodstream through specialized
blood vessels known as high endothelial venules (HEV). B and T
cell areas surround HEV; B cell folicles are located in the outer
cortex and T cells in the diffuse lymphoid tissue of the inner
cortex, also known as paracortex [3].
Stromal cells maintain the microarchitectural organization of
SLO, allowing correct immune cell movement and interaction,
necessary for a protective immune response to pathogens. SLO
stromal cells are divided into four populations, defined by gp38
(podoplanin) and CD31 expression. gp38+CD312 cells (fibroblas-
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tic reticular cells; FRC) form a conduit network for antigen
transport and support of immune cell migration, gp38+CD31+
cells (lymphatic endothelial cells; LEC) build lymph vessels,
gp382CD31+ cells (blood endothelial cells; BEC) construct cortical
vessels and capillaries, including HEV in LN, and gp382CD312
cells (double-negative stromal cells; DN) are a bulk population that
includes follicular dendritic cells (FDC) and extrathymic Aire-
expressing cells [3], [4]. These four populations are well
characterized in LN; FRC, FDC, and BEC are also detected in
spleen, where they are likely to have similar characteristics [5]. In
mouse spleen, gp38+CD31+ LEC are reported to form lymphatic
vessels [6] that originate around central arteries in the white pulp,
join other deep lymphatic vessels that drain into trabeculae, and
exit from the spleen hilum [7]. LEC in spleen lymphatic vessels are
thought to participate in T cell migration, since lymphocytes
within these vessels are CD3+ [7]. FRC and FDC secrete cytokines
and chemokines and express adhesion molecules that modulate
immune cell migration, homeostasis and survival [8], [9], [10].
In SLO, B/T lymphocyte localization and subsequent segrega-
tion depend on chemokines secreted by non-hematopoietic
stromal cells [3], [4]. In homeostasis, primary B cell follicles
contain FDC, which participate in B cell compartment organiza-
tion and in antigen presentation to B cells. The FDC recruit B cells
by secreting CXCL13, which binds to CXCR5 on B cells [11].
The FRC subset forms a network that structures the T cell area
[12], [13]; FRC secrete CCL19 and CCL21, chemokines that
attract CCR7-expressing T cells and DC to facilitate antigen
encounter [8], [14], [15]. FRC constitute the conduit system that
allows small antigens and chemokines to migrate to SLO B and T
cell areas. Large antigens are excluded from this conduit and are
trapped by APC in the spleen MZ or the LN subcapsular sinus.
This system extends mainly through the T cell area and also
reaches B cell follicles, although less densely [16]. CCL19 and
CCL21 are also expressed by BEC and LEC [17].
Members of the TNF family of cytokines have a central role in
lymphoid organ development and organization. Lymphotoxin-a
(LTa), lymphotoxin-b (LTb) and tumor necrosis factor (TNF) have
varying levels of importance in the development of most SLO [18].
Although lymphotoxin signaling is not necessary for spleen
generation, it is needed for red and white pulp segregation, for
functional development of spleen white pulp [13], and for
appropriate homing and maintenance of B/T segregation [19].
The LT receptor (LTbR) is expressed mainly by irradiation-
resistant stromal cells; triggering of LTbR on these cells induces
CXCL13 expression in B cell areas and CCL19 and CCL21 in T
cell areas, via activation of the ‘‘non-canonical’’ IKKa/NIK-
dependent NFkB pathway [20]. LT-deficient mice have disorga-
nized T cell zones; these defects are more severe in spleens of LTa-
and LTbR-deficient than LTb-deficient mice [19]. Impaired
signaling through LTbR reduces spleen CXCL13, CCL19 and
CCL21 levels, leading to disorganization of white pulp areas [21].
LTa also contributes to lymphangiogenesis [22].
p110d is a catalytic subunit of class IA PI3K, together with
p110a and p110b. It shares a catalytic domain with the other
PI3K and binds to a regulatory subunit (p85a or b, p55a, p50a or
p50c). p110d is expressed preferentially in leukocytes, whereas
p110a and p110b are ubiquitous [23]; p110d is also expressed in
neurons [24], in some cancer cell lines [25], [26], and in
endothelial cell lines [26], [27], [28]. p110d has a central role in
immune cell processes, including differentiation, activation and
development of B and T cells [29], [30], [31], [32], [33],
regulatory T cells [34], macrophages [35] and mast cells [36].
p110d is also essential for generation of immune responses, both
primary and secondary (memory) [37], [38]. Analysis of spleen
sections shows a severe reduction in MZ B cells in p110d-deficient
mice [31]. Lack of p110d or its kinase activity greatly impairs
germinal center (GC) formation in the spleen after immunization;
when these GC form, their size and structure are atypical [30],
[31], [32], [39]. These defects in cell segregation and organization
in p110d-deficient mouse SLO suggests that p110d is expressed in
non-hematopoietic stromal cells and that it contributes to the
maintenance of cell segregation and organization.
Given the lack of data on p110d in SLO stromal cells, and on its
role in homing and maintenance of B/T segregation, we studied
p110d expression and function in murine spleen and LN. We
found p110d is expressed in gp382CD31+ and gp38+CD31+
spleen stromal cell subpopulations, where it regulates LTbR
expression as well as CCL19 and CCL21 production; this suggests
a role for p110d in the control of T cell migration to appropriate
spleen areas through the regulation of homeostatic chemokine
production by stromal cells.
Methods
Mice
p110dWT/WT and p110dD910A/D910A mice [30] were bred and
maintained in specific pathogen-free conditions in our animal
facility; the CNB Ethics Committee for Animal Experimentation
approved all animal studies (refs 12021, 12022), in compliance
with national and European Union legislation. All efforts were
made to minimize suffering.
Bone marrow reconstitution assays
p110dWT/WT and p110dD910A/D910A mice were lethally c-
irradiated (single dose, 10 Gy). After 3–4 h, mice were reconsti-
tuted by intravenous injection (tail vein) of total bone marrow from
p110dWT/WT mice. Six weeks after reconstitution, mice were
sacrificed, and spleen and LN collected. Half were frozen for
immunofluorescence studies, and the remainder used to prepare
single-cell suspensions for populations counts and flow cytometry
analysis.
Immune response induction with heat-inactivated
Candida albicans
Heat-inactivated Candida albicans cells (106) were injected into
p110dWT/WT, p110dD910A/D910A, reconstituted p110dWT/WT and
p110dD910A/D910A mice (see Supplement S1 for details). Mice were
sacrificed 5 days post-injection, and spleen and LN collected. Half
were frozen for immunofluorescence studies, and the remainder
used to prepare single-cell suspensions for populations counts and
flow cytometry analysis (see Supplement S1).
Immunofluorescence of SLO sections
Frozen sections of spleen and LN from p110dWT/WT,
p110dD910A/D910A, reconstituted p110dWT/WT and reconstituted
p110dD910A/D910A mice were analyzed by immunofluorescence
staining to study distribution and location of immune cell (Thy1.2+
and CD3+ T cells, MOMA+ MMM, B220+ B cells, CD11c+ DC,
see Supplement S1).
Hematoxylin-eosin staining of spleen sections
Frozen spleen sections from p110dWT/WT, p110dD910A/D910A,
reconstituted p110dWT/WT and reconstituted p110dD910A/D910A
mice were hematoxylin/eosin stained to analyze lymphoid follicle
area (see Supplement S1).
p110d in Spleen Stromal Cells
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Flow cytometry analysis of immune cell populations
Secondary lymphoid organ cells from p110dWT/WT,
p110dD910A/D910A, reconstituted p110dWT/WT and p110dD910A/D910A
mice were processed and stained for flow cytometry analysis (see
Supplement S1).
Flow cytometry analysis of spleen stromal cells
Stromal cells were extracted using an established protocol [40].
Briefly, mouse spleens were removed, pierced with fine forceps,
and placed in ice-cold RPMI-1640 (5 min, on ice). Spleens were
dissected, RPMI-1640 removed, and replaced with 2 ml of a fresh
enzyme mix composed of dispase (0.8 mg/ml; Gibco) and
Figure 1. Immunofluorescence analysis of immune cell distribution andwhite pulp area. Frozen sections of spleen and LN from p110dWT/WT,
p110dD910A/D910A, and reconstituted mice were immunofluorescence-stained to detect T cells (CD3+, Thy1.2+), B cells (B220+), MMM (MOMA+) and DC
(CD11c+). Representative images of spleen (A) and LN (B) sections for all conditions are shown (n=6 mice/condition). Bar = 200 mm. (C) Measurement of
white pulp area in hematoxylin/eosin-stained frozen spleen sections (3 sections/mouse, 6 mice/condition), quantified with ImageJ software. Mean6 SD;
Kolmogorov-Smirnov test, ***p,0.001.
doi:10.1371/journal.pone.0072960.g001
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collagenase IV (0.2 mg/ml; Roche). Tubes were incubated (37uC,
20 min), the cell suspension removed and placed in a fresh tube
with ice-cold FACS buffer (3% FBS, 2 mM EDTA in PBS). The
remaining spleen was re-incubated with 2 ml fresh enzyme mix
(37uC, 10 min), after which the cell suspension was removed and
added to fresh tube above. The remaining spleen was reincubated
(37uC, 15 min) in 2 ml fresh enzyme mix with vigorous pipetting
every 5 min, the cell suspension was removed, placed in the same
tube, whose contents were then filtered through a 100 mm nylon
mesh. Cells were counted and viability assayed using trypan blue.
Cells were stained with CD45 (30-F11, Biolegend), TER119
(TER119, eBioscience), gp38 (8.1.1, eBioscience) and CD31
(MEC 13.3, BD Biosciences) in 100 ml (30 min, 4uC) before
analysis on a Cytomix (Beckman Coulter).
Stromal cell enrichment and cell sorting
Stromal cells were harvested as above. After spleens were fully
digested, cells were centrifuged, counted, and the single cell
suspension depleted of non-hematopoietic stromal cells using
CD45 microbeads in the autoMACS system (Miltenyi) and
Figure 2. Absolute numbers of spleen and LN total cells, CD4+ and CD8+ T cells before and after antigen stimulation. Spleens and LN
were extracted from p110dWT/WT, p110dD910A/D910A, and reconstituted mice in homeostatic conditions (t = 0) and after antigen stimulation (five days
post-injection of inactivated C. albicans, t = 5 d). Whole organ cell suspensions were counted to determine total cell number (A, D) and stained to
determine CD4+ T (B, E) and CD8+ (C, F) cell numbers by flow cytometry (n= 6 mice/condition). Mean 6 SD.
doi:10.1371/journal.pone.0072960.g002
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incubated (20 min, 4uC). CD45-labeled cells were depleted using
the autoMACS Depletes program. Purified stromal cells were
counted and stained before sorting on a FACSAria III (BD
Biosciences).
qRT-PCR analysis of gene expression
Total RNA was extracted from spleen, LN, and sorted cell
populations isolated from p110dWT/WT and p110dD910A/D910A
mouse spleen. qRT-PCR was performed using specific primers for
p110d, CCL19, CCL21, LTa, LTb and LTbR (see Supplement
S1).
Statistics
Data are represented as mean6 SD.Most analyses were performed
using Student’s t-test to compare distinct parameters in two
independent mouse groups (p110dWT/WT and p110dD910A/D910A).
Where indicated, the Kolmogorov-Smirnov test was used to analyze
samples whose distribution is not Gaussian. In all cases, differences
were considered significant for p,0.05 (*p,0.05, **p,0.01,
***p,0.001).
Results
Analysis of SLO after bone marrow reconstitution assays
in homeostatic conditions
To determine whether defects in the MZ and in MZ B cells in
p110dD910A/D910A mouse spleen ([30], Figure S1, Supplemet S1)
were due solely to anomalies in p110dD910A/D910A hematopoietic
cell populations or also to non-hematopoietic stromal cell defects,
we used bone marrow reconstitution assays in p110dWT/WT and
p110dD910A/D910A mice and analyzed SLO in homeostatic
conditions. Lethally irradiated p110dWT/WT and p110dD910A/D910A
mice were reconstituted with total bone marrow from p110dWT/WT
donors. Six weeks after reconstitution, mice were sacrificed for
immunofluorescent staining of spleen and LN sections to detect
immune cell populations (Figure 1); we also analyzed total cell
numbers and lymphoid cell populations of spleen and LN by flow
cytometry (Figure 2).
T cell staining of spleen sections showed fewer T cells and more
diffuse T cell areas in p110dD910A/D910A and reconstituted
p110dD910A/D910A recipient mice than in p110dWT/WT or
p110dWT/WT reconstituted mice (Figure 1A). The defects in the
T cell area were less evident in LN sections, although LN were
consistently slightly smaller in p110dD910A/D910A and reconstituted
p110dD910A/D910A recipients than in p110dWT/WT or p110dWT/WT
reconstituted mice (Figure 1B). Analysis of lymphoid cell distribu-
tion in spleen and LN showed that T cell, B cell, MMM, and DC
patterns in reconstituted p110dWT/WT mice resembled those of
p110dWT/WT mice; in reconstituted p110dD910A/D910A mice, spleen
and LN cell distribution was similar to that of p110dD910A/D910A
mice (Figure 1A, spleen; Figure 1B, LN). The pattern was similar
when spleen white pulp area was measured; the reconstituted mouse
phenotype was thus comparable to that of the recipients (Figure 1C).
This result suggested that the effect of stromal cell subsets on
immune cell distribution and localization is p110d activity-
dependent.
SLO analysis after bone marrow reconstitution and
antigen stimulation
To test whether p110dD910A/D910A mouse SLO structural
defects in homeostasis are corrected after antigen stimulation, we
performed similar studies in bone marrow-reconstituted mice. We
studied spleen and LN immune responses simultaneously using
heat-inactivated C. albicans, which generates concurrent local and
systemic immune responses ([41], [42], Figure S2). We injected
heat-inactivated C. albicans into mice 6 weeks after reconstitution,
and sacrificed mice after five days (Figure S2, Supplement S1).
We analyzed total, CD3+CD4+, and CD3+CD8+ cell number in
p110dWT/WT, p110dD910A/D910A, and bone marrow-reconstituted
mouse spleens in homeostasis and after antigen stimulation
(Figure 2A–C). After stimulation, total cell numbers increased in
spleens from p110dWT/WT but not from p110dD910A/D910A mice
(Figure 2A). CD4+ and CD8+ T cell numbers increased similarly in
p110dWT/WT mouse spleen after stimulation, but not in
p110dD910A/D910A mouse spleen (Figure 2B, C), suggesting
defective T cell expansion in p110dD910A/D910A mice. Total spleen
cell, CD4+ and CD8+ T cell numbers increased after stimulation
compared to homeostatic conditions in reconstituted p110dWT/WT,
but not in p110dD910A/D910A recipient mice (Figure 2A–C),
indicating that spleen stromal cells in p110dD910A/D910A mice might
not contribute appropriately to T cell expansion in response to heat-
inactivated C. albicans. We analyzed total, CD3+CD4+ and
CD3+CD8+ cell number in p110dWT/WT, p110dD910A/D910A, and
bone marrow-reconstituted mouse LN in homeostasis and after
antigen stimulation (Figure 2D–F). LN from p110dWT/WT and
p110dD910A/D910A mice showed an increase in total cell number,
which was smaller in p110dD910A/D910A than in p110dWT/WT mice
(Figure 2D). A similar increase was observed for CD4+ and CD8+ T
cells in LN (Fig. 2E, F), indicating that p110dWT/WT and
p110dD910A/D910A mouse LN respond to C. albicans stimulation,
although the response was slightly lower in p110dD910A/D910A than
in p110dWT/WT mice. After mouse reconstitution, total LN cell
numbers increased after antigenic stimulation in p110dWT/WT, and
to a lesser extent in p110dD910A/D910A recipients (Figure 2D).
Figure 3. Absolute numbers of spleen B cells and DC before
and after antigen stimulation. Spleens were extracted from
p110dWT/WT, p110dD910A/D910A, and reconstituted mice in homeostatic
conditions (t = 0) and after antigen stimulation (five days post-injection
of inactivated C. albicans, t = 5 d). B cell (A) and DC (B) were stained and
cell numbers determined by flow cytometry (n= 6 mice/condition).
Mean 6 SD.
doi:10.1371/journal.pone.0072960.g003
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Figure 4. FACS analysis of stromal cell populations in spleen from p110dWT/WT and p110dD910A/D910A mice. Spleens from p110dWT/WT
and p110dD910A/D910A mice were processed and stained with anti-CD45, -TER119, -CD31, and -gp38 mAb. A) Representative gating strategy for the
analysis of stromal cell populations. Stromal cells were gated via the exclusion of dead, CD45-, and TER119-positive cells. B) Quantification of the
percentage and absolute number of stromal cell populations in spleens of p110dWT/WT and p110dD910A/D910A mice (n=3 experiments/spleen, 6 mice/
group). Student’s t-test, *p,0.05.
doi:10.1371/journal.pone.0072960.g004
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Results were similar for LN CD4+ and CD8+T cells, suggesting that
LN stroma supports the T cell immune response to heat-inactivated
C. albicans.
To determine whether other spleen cell types involved in the
immune response to heat-inactivated C. albicans were affected, we
analyzed B cell (B220+) and dendritic cell (DC, CD11c+) numbers
in p110dWT/WT, p110dD910A/D910A, and bone marrow-reconsti-
tuted mouse spleens in homeostasis and after antigen stimulation
(Figure 3A, B). B cell numbers were increased in p110dWT/WT but
not in p110dD910A/D910A mouse spleen (Figure 3A). DC cell
numbers showed a similar increase in p110dWT/WT spleen after
stimulation, but not in spleens from p110dD910A/D910A mice
(Figure 3B), suggesting defective B cell and DC expansion in
p110dD910A/D910A spleens. B cell and DC numbers increased after
antigen stimulation compared to homeostatic conditions in
reconstituted p110dWT/WT and p110dD910A/D910A recipient mice
(Figure 3A, B). These results suggest that spleen stromal cells
lacking p110d activity contributed to correct B cell and DC
expansion in response to heat-inactivated C. albicans. The defect in
spleen B cell and DC expansion in p110dD910A/D910A mice after
antigen stimulation is probably due to the role of p110d in the
function of these cell types [30], [31], [32], [43].
FACS analysis of spleen stromal cell populations in
p110dWT/WT and p110dD910A/D910A mice
To evaluate the effect of lack of p110d activity on the
percentages and numbers of the four stromal cell subsets defined
by gp38 and CD31 in spleen (FRC, LEC, BEC, DN), we used
FACS to analyze p110dWT/WT and p110dD910A/D910A mouse spleen
cells (Figure 4A). Analysis of CD452TER1192 spleen cells showed a
significant decrease in the percentage of gp382CD31+ cells (BEC) in
p110dD910A/D910A compared to p110dWT/WT mice (Figure 4A). We
also found an increase in total number of gp38+CD312 (FRC) and
gp382CD312 (DN) cells in p110dD910A/D910A compared to
p110dWT/WT mice (Figure 4B).
p110d mRNA expression in spleen stromal cell
populations
To test whether p110d mRNA was expressed in spleen stroma
cells, the four stromal cell subsets defined by gp38/CD31 expression
were sorted from p110dWT/WT and p110dD910A/D910A mouse
spleens and p110d expression analyzed by RT-PCR. As a positive
control, CD45+ (lymphoid) cells were also sorted. Although
lymphoid cells express higher p110d mRNA levels, gp38+CD31+
cells (LEC) and to a lesser extent, gp382CD31+ cells (BEC) also
expressed p110dmRNA, whereas gp38+CD312 (FRC) cells did not
(Figure 5). Within the LEC population, p110d mRNA levels were
notably reduced in p110dD910A/D910A, whereas they were similar in
BEC and lymphoid cells (Figure 5).
qRT-PCR of homeostatic chemokines and TNF family
members in spleen, LN and spleen stromal cell subsets in
p110dWT/WT and p110dD910A/D910A mice
T lymphocyte homing and retention in SLO depends on
secretion of the homeostatic chemokines CCL19, CCL21 and
CXCL13 by non-hematopoietic stromal cells. LTa, LTb, and
TNF trigger stromal cell production of these homeostatic
chemokines. We used qRT-PCR to analyze the expression of
CCL19 and CCL21 and of TNF family proteins (LTa, LTb, LTb-
receptor) in total RNA extracts of whole spleens and LN from
p110dWT/WT and p110dD910A/D910A mice. Expression of CCL21
and to a lesser extent, that of CCL19 were lower in total RNA
extracts from p110dD910A/D910A than from p110dWT/WT mouse
spleens (Figure 6A); there were no differences in LN from either
genotype (Figure 6B). Analysis of mRNA levels of TNF family
proteins or their receptor LTbR showed no differences in spleen
or LN (Figure 6A, B).
To better define the defects identified in whole spleen extracts,
we separated the spleen gp38/CD31-defined stromal cell subsets
by cell sorting and analyzed chemokine and TNF family mRNA
expression in extracts of each population. Analysis showed a
reduction in CCL19 mRNA levels only in p110dD910A/D910A
gp382CD31+ (BEC) compared to p110dWT/WT; gp38+CD312
(FRC) and gp38+CD31+ (LEC) subsets expressed the highest levels
(Figure 6C). CCL21 mRNA levels were slightly reduced in all
spleen stromal populations, with the highest levels in gp38+CD312
(FRC, Figure 6C). These chemokines were barely detectable in
lymphoid cells (Figure 6C).
For TNF family proteins, the gp38+CD312 (FCR) p110dD910A/D910A
population expressed the highest LTa levels, whereas p110dD910A/
D910A gp38+CD31+ (LEC) showed a significant reduction compared
with p110dWT/WT. LTb was produced mainly by lymphoid
cells and by gp38+CD312 (FRC), and p110dWT/WT and
p110dD910A/D910A populations showed no notable differences.
LTbR was expressed mainly by gp38+CD312 (FRC) and
gp38+CD31+ (LEC) in p110dWT/WT, with greatly reduced expres-
sion in p110dD910A/D910A gp38+CD31+ (LEC) (Figure 6C).
Discussion
The immune response is controlled by lymphoid and stromal
cell function and location in SLO [4]. The PI3K p110d isoform is
expressed preferentially by leukocytes, although it is also detected
in other cell types [24], [25], [26], [27], [28]. MZ B cell numbers
are extremely low in p110d-deficient mouse spleen [31], and lack
of p110d or its kinase activity severely impairs germinal center
(GC) formation in the spleen after immunization [30], [31], [32],
[39]. We tested whether this isoform is expressed in SLO stromal
Figure 5. p110d mRNA expression in spleen stromal cell
populations from p110dWT/WT and p110dD910A/D910A mice. Total
RNA was extracted from sorted p110dWT/WT and p110dD910A/D910A
spleen stromal cell subsets (n=5 mice/genotype). Lymphoid cells
(CD45+) were sorted as control. Expression of p110d mRNA was
analyzed by qRT-PCR. Normalized quantities (mean 22DCt) of p110d
mRNA are shown.
doi:10.1371/journal.pone.0072960.g005
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cells, and whether expression mediates cell location and
compartimentalization in these organs.
Reconstitution assays have been used to analyze and confirm
specific p110d functions in memory T cells; lethally irradiated WT
mice were reconstituted with purified memory T cell subsets
(CD62Lhi central memory T cells and CD62Llo effector memory
T cells) from p110dD910A/D910A and p110dWT/WT mice [35].
Using reconstitution assays with total bone marrow from
Figure 6. qRT-PCR analysis of homeostatic chemokines and TNF family members in spleen, LN and spleen stromal cell subsets from
p110dWT/WT and p110dD910A/D910A mice. Total RNA was extracted from p110dWT/WT and p110dD910A/D910A spleen, LN, and sorted spleen stromal
cell subsets (n= 5 mice/genotype). Expression of CCL19, CCL21, LTa, LTb and LTbR was analyzed by qRT-PCR in spleen (A), LN (B), and stromal cell
subsets (C). Normalized quantities (mean 22DCt) of mRNA are depicted. Student’s t-test, *p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0072960.g006
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p110dWT/WT mice, we tested whether stromal cells have a role in
SLO reconstitution (p110dWT/WT-reconstituted p110dWT/WT,
p110dWT/WT-reconstituted p110dD910A/D910A mice). Immunohis-
tochemical analysis of p110dD910A/D910A and reconstituted
p110dD910A/D910A recipient mouse spleen showed reduced T cell
staining and more diffuse T cell areas than in p110dWT/WT or
p110dWT/WT reconstituted mice. In addition, in p110dD910A/D910A
mice reconstituted with p110dWT/WT bone marrow, spleen CD4+
and CD8+ T cell numbers did not increase in response to heat-
inactivated C. albicans, suggesting that a p110dD910A/D910A stroma
defect impedes a correct immune response. We thus hypothesized a
role for p110d in stromal cell function in the spleen.
SLO stromal cells are divided into four populations as defined
by gp38 and CD31 expression, LEC (gp38+CD31+), FRC
(gp38+CD312), BEC (gp382CD31+), and double negative cells
(gp382CD312) [3], [4]. FACS analysis of spleen stromal cell
populations showed a significant decrease in the percentage of
gp382CD31+ cells in p110dD910A/D910A mice, which paralleled an
increase in total gp38+CD312 and gp382CD312 cells. This result
suggested that p110d is expressed differently in each spleen
stromal population. As there are no reports of p110d expression in
SLO stromal cell subsets, we sorted the four subpopulations from
p110dWT/WT and p110dD910A/D910A spleen and tested for p110d
mRNA expression by qRT-PCR. In addition to its expression in
lymphoid cells, p110d was detected in spleen LEC and BEC
subsets. p110d mRNA levels in LEC were significantly lower in
p110dD910A/D910A than in p110dWT/WT spleen.
T homing and compartmentalization in SLO requires chemo-
kine secretion by stromal cells. FRC secrete the homeostatic
chemokines CCL19 and CCL21 [3], which are also produced by
LEC and BEC [17]. Analysis of their expression in total RNA
extracts of p110dD910A/D910A spleen showed significantly lower
levels of CCL21 and, to a lesser extent, of CCL19 than
p110dWT/WT spleen; comparison of p110dD910A/D910A and
p110dWT/WT LN showed no differences in CCL19 and CCL21
levels. The spleen defects led us to analyze chemokine expression
in the four stromal subpopulations. Lack of p110d catalytic activity
significantly impaired CCL19 production by BEC, and reduced
CCL21 production in all populations. This CCL19 and CCL21
expression defect in the stromal cells could give rise to the
abnormal B/T cell segregation observed in p110d mouse spleen.
LTa, LTb and TNF participate to some degree in the
development of most SLO [18]. Lymphotoxin signaling is
necessary for red and white pulp segregation, as well as for
correct B/T cell homing and maintenance of segregation [19]. We
found no differences in spleen or LN LTa and LTb expression
between p110dWT/WT and p110dD910A/D910A mice. When we
analyzed mRNA in specific spleen stromal cell populations,
however, expression of LTa and LTbR expression were signifi-
cantly lower in p110dD910A/D910A LEC and somewhat less so in
BEC compared to those of p110dWT/WT mice; no differences were
observed in LTb expression. LTa2/2, LTb2/2 and LTbR2/2
defects differed in SLO [44], [45], [46] [47]. The p110dD910A/D910A
spleen phenotype is similar to that of mice in which LTab-LTbR
interaction is blocked by a soluble LTbR-IgG1 fusion protein [48],
and includes loss of MZ and of T/B cell segregation, although
segregation was normal in LN. Low LTbR expression in LEC and
BEC appears to be the primary cause of these spleen defects in
p110dD910A/D910A mice, together with low CCL19 and CCL21
production, which affects T/B cell migration and compartmental-
ization. The need for LTa for B/T cell segregation in spleen white
pulp, whereas TNFR-I is necessary for B/T cell segregation in LN
[49], is consistent with the lesser defects in p110dD910A/D910A LN
compared with spleen.
In summary, we found p110d expression by gp382CD31+ and
gp38+CD31+ spleen stromal cells. Lack of p110d activity in these
populations correlated with lower LTbR, CCL19 and CCL21
mRNA levels. These findings could explain the lower T cell numbers
and more diffuse T cell areas observed in p110dD910A/D910A mouse
spleen, and the lower T cell expansion after antigen stimulation
observed in p110dD910A/D910A compared with p110dWT/WT.
Supporting Information
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Figure S1 Distribution of immune cell types from
p110dWT/WT and p110dD910A/D910A spleen marginal zone.
Histological sections from p110dWT/WT and p110dD910A/D910A
spleens were immunofluorescent stained for marginal zone
immune cell types. (A) MZB (B220+ surrounding MOMA+ cells
around spleen follicles) and MMM (MOMA+) (n=4 mice/
genotype). (B) MZM (SIGNR1+) and MMM (MOMA+) (n=4
mice/genotype). Bar = 200 mm.
(TIF)
Figure S2 Immune response in p110dWT/WT mice in-
jected with heat-inactivated C. albicans. p110dWT/WT mice
received i.p. injections of heat-inactivated C. albicans for the
indicated times (0, 2, 5, 7, 9 and 21 d) to stimulate an immune
response. Total CD4+ T cells from p110dWT/WT spleens (A) and
LN (B) were counted before (t = 0) and several times after C.
albicans injection (n=6–10 mice). Mean 6 SD.
(TIF)
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